Growth Metrics

Stereotaxis (STXS) Work In Process (2011 - 2026)

Stereotaxis (STXS) reported Work In Process of $1.9 million for Q1 2026, up 123.83% year-over-year from $852000.0 in Q1 2025, and down 14.48% on a QoQ basis from $2.2 million in Q4 2025.

Stereotaxis (STXS) has 16 years of Work In Process data on file, last reported at $1.9 million in Q1 2026.

  • Quarterly Work In Process rose 123.83% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 123.83% YoY) and the FY2025 annual result came in at $2.2 million, up 102.18% from the prior year.
  • Work In Process slipped to $1.9 million in Q1 2026 per STXS's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Work In Process topped out at $2.2 million in Q4 2025 and bottomed at $267000.0 in Q2 2023.
  • The 5-year median for Work In Process is $852000.0 (2025), against an average of $953352.9.
  • The widest annual swing landed in 2023, when Work In Process sank 81.0%; it then soared 316.48% in 2024.
  • Tracing STXS's Work In Process over 5 years: stood at $530000.0 in 2022, then jumped by 95.09% to $1.0 million in 2023, then grew by 6.67% to $1.1 million in 2024, then surged by 102.18% to $2.2 million in 2025, then fell by 14.48% to $1.9 million in 2026.
  • Per Business Quant, the three latest STXS Work In Process figures stand at $1.9 million (Q1 2026), $2.2 million (Q4 2025), and $728000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.91 Mn
Dec 31, 2025 2.23 Mn
Sep 30, 2025 728,000.00
Jun 30, 2025 1.51 Mn
Mar 31, 2025 852,000.00
Dec 31, 2024 1.10 Mn
Sep 30, 2024 893,000.00
Jun 30, 2024 1.11 Mn
Mar 31, 2024 457,000.00
Dec 31, 2023 1.03 Mn
Sep 30, 2023 542,000.00
Jun 30, 2023 267,000.00
Mar 31, 2023 425,000.00
Dec 31, 2022 530,000.00
Sep 30, 2022 384,000.00
Jun 30, 2022 1.41 Mn
Mar 31, 2022 830,000.00
Dec 31, 2021 133,000.00
Sep 30, 2021 847,847.00
Jun 30, 2021 919,214.00
Mar 31, 2021 800,034.00
Dec 31, 2020 433,026.00
Sep 30, 2020 521,018.00
Jun 30, 2020 563,838.00
Mar 31, 2020 454,135.00
Dec 31, 2019 515,262.00
Sep 30, 2019 275,745.00
Jun 30, 2019 179,408.00
Mar 31, 2019 133,218.00
Dec 31, 2018 2,594.00
Sep 30, 2018 51,341.00
Jun 30, 2018 353,800.00
Mar 31, 2018 197,820.00
Dec 31, 2017 4,836.00
Sep 30, 2017 332,057.00
Jun 30, 2017 403,863.00
Mar 31, 2017 349,597.00
Dec 31, 2016 341,125.00
Sep 30, 2016 679,114.00
Jun 30, 2016 876,105.00
Mar 31, 2016 427,952.00
Dec 31, 2015 24,758.00
Sep 30, 2015 3,893.00
Jun 30, 2015 249,022.00
Mar 31, 2015 428,192.00
Dec 31, 2014 374,236.00
Sep 30, 2014 444,550.00
Jun 30, 2014 385,642.00
Mar 31, 2014 190,296.00
Dec 31, 2013 364,779.00
Sep 30, 2013 432,759.00
Jun 30, 2013 330,938.00
Mar 31, 2013 319,954.00
Dec 31, 2012 65,546.00
Sep 30, 2012 499,121.00
Jun 30, 2012 354,344.00
Dec 31, 2011 131,980.00